I agree that this site is using cookies. You can find further informations here.
X
Matsushima, Nobuko
48  results:
Search for persons X
?
1

Summary Report of a Public Workshop: Case Studies of Multi‐..:

Matsushima, Nobuko ; Otsubo, Yasuto ; Aoi, Yoko...
Clinical Pharmacology & Therapeutics.  115 (2024)  5 - p. 965-970 , 2024
Link: https://doi.org/10.1002/..
 
?
2

A State-of-the-Art Roadmap for Biomarker-Driven Drug Develo..:

Serelli-Lee, Victoria ; Ito, Kazumi ; Koibuchi, Akira...
Journal of Personalized Medicine.  12 (2022)  5 - p. 669 , 2022
Link: https://doi.org/10.3390/..
 
?
3

Current Status, Issues and Future Prospects of Personalized..:

Yamamoto, Yuichi ; Kanayama, Norihiro ; Nakayama, Yusuke.
Journal of Personalized Medicine.  12 (2022)  3 - p. 444 , 2022
Link: https://doi.org/10.3390/..
 
?
4

Pharmacokinetics and safety of rilpivirine in healthy Japan..:

Ohta, Kentaro ; Matsushima, Nobuko ; Tanii, Hiromi...
Drug Metabolism and Pharmacokinetics.  41 (2021)  - p. 100422 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Efficacy and safety of ustekinumab in East Asian patients w..:

Hisamatsu, Tadakazu ; Kim, Hyo Jong ; Motoya, Satoshi...
Intestinal Research.  19 (2021)  4 - p. 386-397 , 2021
Link: https://doi.org/10.5217/..
 
?
6

Efficacy and safety of ustekinumab in Japanese patients wit..:

Hibi, Toshifumi ; Imai, Yuya ; Murata, Yoko...
Intestinal Research.  15 (2017)  4 - p. 475 , 2017
Link: https://doi.org/10.5217/..
 
?
7

Platelet Aggregation Inhibitory Effects and Pharmacokinetic..:

Umemura, Kazuo ; Ikeda, Yasuhiko ; Matsushima, Nobuko.
Clinical Pharmacology in Drug Development.  6 (2016)  4 - p. 398-407 , 2016
Link: https://doi.org/10.1002/..
 
?
8

Population pharmacokinetic analysis of patritumab, a HER3 i..:

Yoshiba, Satoshi ; Jansen, Mendel ; Matsushima, Nobuko..
Cancer Chemotherapy and Pharmacology.  77 (2016)  5 - p. 987-996 , 2016
Link: https://doi.org/10.1007/..
 
?
9

Edoxaban drug–drug interactions with ketoconazole, erythrom..:

Parasrampuria, Dolly A. ; Mendell, Jeanne ; Shi, Minggao...
British Journal of Clinical Pharmacology.  82 (2016)  6 - p. 1591-1600 , 2016
Link: https://doi.org/10.1111/..
 
?
10

Linear mixed‐effects model of QTc prolongation for olmesart..:

Song, SaeHeum ; Matsushima, Nobuko ; Lee, James.
The Journal of Clinical Pharmacology.  56 (2015)  1 - p. 96-100 , 2015
Link: https://doi.org/10.1002/..
 
?
11

A thorough QTc study demonstrates that olmesartan medoxomil..:

Mendell, Jeanne ; Matsushima, Nobuko ; O'Reilly, Terry E..
The Journal of Clinical Pharmacology.  56 (2015)  4 - p. 484-491 , 2015
Link: https://doi.org/10.1002/..
 
?
12

Bioavailability and Safety of the Factor Xa Inhibitor Edoxa..:

Matsushima, Nobuko ; Lee, Frank ; Sato, Toshiyuki..
Clinical Pharmacology in Drug Development.  2 (2013)  4 - p. 358-366 , 2013
Link: https://doi.org/10.1002/..
 
?
13

Drug-Drug Interaction Studies of Cardiovascular Drugs Invol..:

Mendell, Jeanne ; Zahir, Hamim ; Matsushima, Nobuko...
American Journal of Cardiovascular Drugs.  13 (2013)  5 - p. 331-342 , 2013
Link: https://doi.org/10.1007/..
 
?
14

Quantitative determination of olmesartan in human plasma an..:

Liu, Dongyang ; Hu, Pei ; Matsushima, Nobuko...
Journal of Chromatography B.  856 (2007)  1-2 - p. 190-197 , 2007
Link: https://doi.org/10.1016/..
 
?
15

Assessment of Dosing Impact on Intra-Individual Variability..:

Krzyzanski, Wojciech ; Dmochowski, Jacek ; Matsushima, Nobuko.
Journal of Pharmacokinetics and Pharmacodynamics.  33 (2006)  5 - p. 635-655 , 2006
Link: https://doi.org/10.1007/..
 
1-15